Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Shareholders' Equity

v3.21.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
Total
Warrants [Member]
Share Capital [Member]
Contributed Surplus [Member]
Accumulated other comprehensive Income
Accumulated Deficit
Balance, shares at Dec. 31, 2019     160,478,059      
Balance, amount at Dec. 31, 2019 $ 44,333,000 $ 0 $ 185,754,000 $ 20,317,000 $ 3,654,000 $ (165,392,000)
Stock compensation 234,000 0 0 234,000 0 0
Comprehensive income (loss) (3,614,000) 0 $ 0 0 27,000 (3,641,000)
Balance, shares at Mar. 31, 2020     160,478,059      
Balance, amount at Mar. 31, 2020 40,953,000 0 $ 185,754,000 20,551,000 3,681,000 (169,033,000)
Balance, shares at Dec. 31, 2020     170,253,752      
Balance, amount at Dec. 31, 2020 34,096,000 0 $ 189,620,000 20,946,000 3,707,000 (180,177,000)
Stock compensation 231,000 0 0 231,000 0 0
Comprehensive income (loss) (7,153,000) 0 $ 0 0 219,000 (7,372,000)
Exercise of stock options, shares     1,723,818      
Exercise of stock options, amount 1,078,000 0 $ 1,540,000 (462,000) 0 0
Exercise of warrants, shares     481,000      
Exercise of warrants, amount 551,000 0 $ 551,000 0 0 0
Shares issued for cash, shares     16,930,530      
Shares issued for cash, amount 15,237,000 169,000 $ 15,068,000 0 0 0
Less amount assigned to warrant liablity (2,604,000) (169,000) (2,435,000) 0 0 0
Less share issue costs (1,307,000) 0 $ (1,307,000) 0 0 0
Balance, shares at Mar. 31, 2021     189,389,100      
Balance, amount at Mar. 31, 2021 $ 40,129,000 $ 0 $ 203,037,000 $ 20,715,000 $ 3,926,000 $ (187,549,000)